Tezosentan in the treatment of acute heart failure.

about

Comparison of the pharmacokinetics, pharmacodynamics and tolerability of tezosentan between caucasian and Japanese subjects.Effect of intra-abdominal pressure on hepatic microcirculation: implications of the endothelin-1 receptor.

P2860

Q35827520-264AE05B-8605-48DF-A955-DAB081950723 Q50491878-78037131-0715-497E-A270-A0A2A0A4F960

P2860

Tezosentan in the treatment of acute heart failure.

Item

http://www.wikidata.org/entity/Q35590982

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Tezosentan in the treatment of acute heart failure.

@ast

Tezosentan in the treatment of acute heart failure.

@en

type

Item

label

Tezosentan in the treatment of acute heart failure.

@ast

Tezosentan in the treatment of acute heart failure.

@en

prefLabel

Tezosentan in the treatment of acute heart failure.

@ast

Tezosentan in the treatment of acute heart failure.

@en

P1476

Tezosentan in the treatment of acute heart failure.

@en

P2093

John G Gums

http://www.w3.org/2001/XMLSchema#string

John M Tovar

http://www.w3.org/2001/XMLSchema#string

P2860

Selected highlights from the 50th Annual Scientific Session of the American College of Cardiology, Orlando, USA, 18-21 March 2001

Clinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology--WARIS II, ESCAMI, PAFAC, RITZ-1 and TIME

Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1

Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs.

Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure.

The use of the endothelin receptor antagonist, tezosentan, before or after renal ischemia protects renal function.

Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.

Endothelin as a therapeutic target in the treatment of cardiovascular disease.

Chronic oral endothelin type A receptor antagonism in experimental heart failure.

Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist.

P304

1877-1883

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1345/APH.1D080

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14632537

http://www.w3.org/2001/XMLSchema#string

Tezosentan in the treatment of acute heart failure.

about

P2860

P2860

Tezosentan in the treatment of acute heart failure.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698